Covid-19 vaccine: MOH regulator has received relevant clinical data from Pfizer, says KJ

By HEMANANTHANI SIVANANDAM, RAHIMY RAHIM, MARTIN CARVALHO and TARRENCE TAN

KUALA LUMPUR: The National Pharmaceutical Regulatory Agency (NPRA) under the Health Ministry has received the clinical data from Pfizer on the Covid-19 vaccine, says Khairy Jamaluddin.

The Science, Technology and Innovations Minister said the decision to use the Pfizer vaccine lies with the NPRA, which would need to register and approve the vaccine, and the Health Ministry.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Dewan Rakyat , Parliament , National Pharmaceutical Regulatory Agency , NPRA , Covid-19 Vaccine , Pfizer , Khairy Jamaluddin

Next In Nation
Kiandee, Hamzah should be responsible for PN’s heavy losses at Sabah polls, say state Bersatu leaders
Pahang civil servants to receive special financial aid equal to two months' salary
M-cyclists flock to free engine oil change, helmet exchange booths at Madani event
Immigration raids in Kulai, Pontian nabs 37 foreigners for overstaying, violating passes
Poignant moment as King launches Tunku Laksamana Johor Cancer Centre
NSE diversions to facilitate Yong Peng-Senai route construction, say PLUS
‘Parliament will not be the same without him’ says Abdul Karim of Bung Moktar’s passing
Kedah MP arrested over alleged corruption in state-owned cattle project
Hajiji pays last respects to Bung Moktar
Sabah has lost 'a golden son', says former Chief Justice

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.